A Panel of Immunohistochemical Stains Assists in the Distinction Between Ovarian and Renal Clear Cell Carcinoma

&NA; The diagnosis of primary clear cell carcinoma of the ovary or kidney is usually straightforward. However, problems in ascertaining the site of the primary tumor may arise when there is widespread metastatic disease or when clear cell carcinoma is present in both the ovary and kidney. In this study, the value of a panel of antibodies in distinguishing between an ovarian and renal clear cell carcinoma was evaluated. The panel comprised cytokeratin (CK)7 and 20, vimentin, estrogen receptor (ER), CD10, and renal cell carcinoma (RCC) marker. Ovarian clear cell carcinomas (n = 14) were positive with CK7 (14/14), vimentin (6/14), ER (2/14), and RCC marker (2/14). All were negative with CD10 and CK20. Renal clear cell carcinomas (n = 14) were positive with CD10 (14/14), RCC marker (14/14), vimentin (7/14), CK7 (2/14), and CK20 (1/14). All were negative with ER. This panel allows clear cell carcinomas of the ovary and kidney to be distinguished with a high degree of certainty and is a useful adjunct to histologic examination. Primary ovarian clear cell carcinomas are characterized by CK7 positivity, whereas primary renal neoplasms are characterized by positivity for CD10 and RCC marker and negative staining with CK7.

[1]  A. Tzankov,et al.  Glottis oedema and interstitial pulmonary disease as a result of extramedullary haemopoiesis in polycythaemia vera rubra causing asphyctic death , 2003, Journal of clinical pathology.

[2]  M. Mathers,et al.  Cytokeratin 7: a useful adjunct in the diagnosis of chromophobe renal cell carcinoma , 2002, Histopathology.

[3]  W. McCluggage,et al.  Recent advances in immunohistochemistry in gynaecological pathology , 2002, Histopathology.

[4]  L. Truong,et al.  Diagnosing Primary and Metastatic Renal Cell Carcinoma: The Use of the Monoclonal Antibody `Renal Cell Carcinoma Marker' , 2001, The American journal of surgical pathology.

[5]  P. Maxwell,et al.  CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms , 2001, Histopathology.

[6]  M. Deavers,et al.  Immunohistochemical Analysis of Clear Cell Carcinoma of the Gynecologic Tract , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[7]  M. Heatley,et al.  The Value of Immunocytochemistry in Distinguishing Between Clear Cell Carcinoma of the Kidney and Ovary , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[8]  Rajesh C. Dash,et al.  Malignancy in Endometriosis: Frequency and Comparison of Ovarian and Extraovarian Types , 2001, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[9]  P. Chu,et al.  Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 Cases , 2000, Modern Pathology.

[10]  W. McCluggage,et al.  Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasms , 2000, Journal of clinical pathology.

[11]  P. Chu,et al.  Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. , 2000, American journal of clinical pathology.

[12]  A. Renshaw,et al.  Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. , 2000, The American journal of surgical pathology.

[13]  B. Delahunt,et al.  Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[14]  G. Ueda,et al.  Immunohistochemical study of cytokeratin 7 for the differential diagnosis of adenocarcinomas in the ovary. , 1993, Gynecologic oncology.

[15]  J. R. Spencer,et al.  Metastatic renal tumor presenting as ovarian clear cell carcinoma. , 1993, Urology.

[16]  R. Young,et al.  Renal Cell Carcinoma Metastatic to the Ovary: A Report of Three Cases Emphasizing Possible Confusion With Ovarian Clear Cell Adenocarcinoma , 1992, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

[17]  C. Biscotti,et al.  Ovarian clear cell adenocarcinoma. , 1989, Gynecologic oncology.

[18]  R. Warnke,et al.  An immunoperoxidase study of renal cell carcinomas: correlation with nuclear grade, cell type, and histologic pattern. , 1988, Human pathology.

[19]  G. Fleuren,et al.  Immunohistochemical analysis of monoclonal antibodies to renal antigens. Application in the diagnosis of renal cell carcinoma. , 1986, The American journal of pathology.

[20]  E. Tanagho,et al.  Renal-cell carcinoma metastatic to the ovary. A case report. , 1983, The Journal of reproductive medicine.

[21]  J. Hobbs,et al.  Bilateral Ovarian Metastases from Renal Adenocarcinoma: Report of a case and discussion of pathogenesis , 1957, Obstetrics and gynecology.

[22]  Hobbs Je,et al.  Bilateral ovarian metastases from renal adenocarcinoma; report of a case and discussion of pathogenesis. , 1957 .

[23]  H. Kiguchi,et al.  [Renal cell carcinoma metastatic to the ovary: a case report]. , 2001, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology.

[24]  D. Arber,et al.  CD10: A Review , 1997 .

[25]  G. Pallesen,et al.  Expression of segment-specific antigens in the human nephron and in renal epithelial tumors. , 1988, APMIS. Supplementum.

[26]  C. Manlove,et al.  Vaginal and ovarian metastases from hypernephroma; report of case and review of literature. , 1949, Surgery, gynecology & obstetrics.